Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ernest

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Infectious Diseases|February 17, 2025
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine ModelsBernard Ngara, Lorenzo Flori, Rob Christiaan van Wijk, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2021
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary TuberculosisJacqueline P Ernest, Jansy Sarathy, Ning Wang, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2025
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis diseaseNathan Peroutka-Bigus, Elizabeth J Brooks, Michelle E Ramey, et al.
The Journal of Infectious Diseases|June 4, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of ResistanceAnnamarie E Bustion, Jacqueline P Ernest, Firat Kaya, et al.
Nature Communications|August 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimenNatasha Strydom, Jacqueline P Ernest, Marjorie Imperial, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2023
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 TrialElizabeth Roof, Cheri L Deal, Shawn E McCandless, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Infectious Diseases|February 17, 2025
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine ModelsBernard Ngara, Lorenzo Flori, Rob Christiaan van Wijk, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2021
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary TuberculosisJacqueline P Ernest, Jansy Sarathy, Ning Wang, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2025
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis diseaseNathan Peroutka-Bigus, Elizabeth J Brooks, Michelle E Ramey, et al.
The Journal of Infectious Diseases|June 4, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of ResistanceAnnamarie E Bustion, Jacqueline P Ernest, Firat Kaya, et al.
Nature Communications|August 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimenNatasha Strydom, Jacqueline P Ernest, Marjorie Imperial, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2023
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 TrialElizabeth Roof, Cheri L Deal, Shawn E McCandless, et al.
Pageof 3